S
STEK
vs
S&P 500
S&P 500
Over the past 12 months, STEK has underperformed S&P 500, delivering a return of -99% compared to the S&P 500's +17% growth.
Stocks Performance
STEK vs S&P 500
Performance Gap
STEK vs S&P 500
Performance By Year
STEK vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Stemtech Corp
Glance View
Stemtech Corp. engages in the development of nutritional supplements. The company is headquartered in Naples Florida, Florida and currently employs 45 full-time employees. The company went IPO on 2014-09-15. The firm is also known as Stem Cell Nutrition Company. The firm's products enhance and support the work of the body's stem cells by releasing more stem cells, helping to circulate them in the blood and migrate them into tissues, where they can perform their daily function of renewal for optimal health. These products are marketed internationally by the Companies subsidiaries and through independent distributors. The firm markets its products under various brands, which include RCM System, stemrelease3, Stemflo MigraStem, OraStem (Oral Health Care), and D-Fuze (Electromagnetic Frequency blocker). The company also introduced a skincare product, Cellect One Rapid Renew Stem Cell Peptide Night Cream. Its segments include North America, Latin America and Asia.
